Crossmark

Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05407-1

Published Online: 2021-07-08

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yuyi

Yu, Mingwei

Liu, Zishen

Zhang, Yi

Li, Qiwei

Yang, Guowang https://orcid.org/0000-0002-0799-3864
Funding

Funding for this research was provided by:

National Key Research & Development Program of China (2018YFC1705101)
License Information

Text and Data Mining valid from 2021-07-08

Version of Record valid from 2021-07-08
More Information

Article History

Received: 13 September 2020

Accepted: 29 June 2021

First Online: 8 July 2021

Declarations

:

: Before recruitment, we have registered the protocol in the Chinese Clinical Trial Registry (No. ChiCTR1900022991, 6 May 2019). The study was ethically approved (2019L02-009-01) by the Research Ethical Committees at Beijing Hospital of the Traditional Chinese Medicine, Capital Medical University. The informed consent will be obtained from all study participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below